Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
0.6601
-0.0106 (-1.58%)
At close: Nov 28, 2025, 1:00 PM EST
0.6740
+0.0139 (2.11%)
After-hours: Nov 28, 2025, 4:43 PM EST
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $1.11M in the quarter ending September 30, 2025, with 27.46% growth. This brings the company's revenue in the last twelve months to $3.29M, up 3.26% year-over-year. In the fiscal year ending June 30, 2025, Intelligent Bio Solutions had annual revenue of $3.05M, down -1.90%.
Revenue (ttm)
$3.29M
Revenue Growth
+3.26%
P/S Ratio
1.29
Revenue / Employee
$59,855
Employees
55
Market Cap
6.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.05M | -59.25K | -1.90% |
| Jun 30, 2024 | 3.11M | 1.85M | 147.58% |
| Jun 30, 2023 | 1.26M | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | 1.98M | 1.79M | 949.30% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
INBS News
- 9 days ago - Intelligent Bio Solutions to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025 - Newsfile Corp
- 17 days ago - Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth - GlobeNewsWire
- 25 days ago - Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480 - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System - GlobeNewsWire
- 3 months ago - Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July - GlobeNewsWire